A signature for immune response correlates with HCV treatment outcome in Caucasian subjects
Authors:
Open Access
- 1 June 2015
- journal article
- Published by Elsevier in Data in Brief
- Vol. 3, 56-61
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- A signature for immune response correlates with HCV treatment outcome in Caucasian subjectsJournal of Proteomics, 2015
- 14 ALL-ORAL SOFOSBUVIR-BASED 12-WEEK REGIMENS FOR THE TREATMENT OF CHRONIC HCV INFECTION: THE ELECTRON STUDYJournal of Hepatology, 2013
- 3 SAFETY AND EFFICACY OF INTERFERON-FREE REGIMENS OF ABT-450/r, ABT-267, ABT-333 +/− RIBAVIRIN IN PATIENTS WITH CHRONIC HCV GT1 INFECTION: RESULTS FROM THE AVIATOR STUDYJournal of Hepatology, 2013
- Perspectives and challenges of interferon-free therapy for chronic hepatitis CJournal of Hepatology, 2013
- 1399 12-WEEK INTERFERON-FREE REGIMEN OF ABT-450/R +ABT-333 +RIBAVIRIN ACHIEVED SVR12 IN MORE THAN 90% OF TREATMENT-NAIVE HCV GENOTYPE-1-INFECTED SUBJECTS AND 47% OF PREVIOUS NON-RESPONDERSJournal of Hepatology, 2012
- Effects of anti-viral therapy and HCV clearance on cerebral metabolism and cognitionJournal of Hepatology, 2012
- 60 SILEN-C1: SUSTAINED VIROLOGIC RESPONSE (SVR) AND SAFETY OF BI201335 COMBINED WITH PEGINTERFERON ALFA-2A AND RIBAVIRIN (P/R) IN TREATMENT-NAIVE PATIENTS WITH CHRONIC GENOTYPE 1 HCV INFECTIONJournal of Hepatology, 2011
- 66 SILEN-C2: SUSTAINED VIROLOGIC RESPONSE (SVR) AND SAFETY OF BI201335 COMBINED WITH PEGINTERFERON ALFA-2A AND RIBAVIRIN (P/R) IN CHRONIC HCV GENOTYPE-1 PATIENTS WITH NON-RESPONSE TO P/RJournal of Hepatology, 2011
- Regularization Paths for Generalized Linear Models via Coordinate Descent2010
- Controlling the False Discovery Rate: A Practical and Powerful Approach to Multiple TestingJournal of the Royal Statistical Society Series B: Statistical Methodology, 1995